Get all your news in one place.
100's of premium titles.
One app.
Start reading
Salon
Salon
Science
Nicole Karlis

Biden suffers a Paxlovid "rebound"

Pfizer's Paxlovid is displayed on July 07, 2022 in Pembroke Pines, Florida. The US Food and Drug Administration revised the emergency use authorization for Paxlovid, Pfizer's Covid-19 antiviral treatment, to allow state-licensed pharmacists to prescribe the treatment to people. Joe Raedle/Getty Images

President Joe Biden isn't in the clear with COVID just yet. After testing negative for COVID-19 last week, press secretary Karine Jean-Pierre said in a memo on Monday that Biden's latest antigen test was still positive. That means that Biden tested positive — again — after a period of testing negative. While President Biden has reportedly not experienced a re-emergence of symptoms, he is still presumed to be contagious and will be working remotely.

The unusual results pattern doesn't mean that Biden experiencing an immediate reinfection. Rather, Biden has become yet another victims of what is sometimes called a "Paxlovid rebound."

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.